Prospective screening for monkeypox infection among users of HIV pre-exposure prophylaxis in Denmark

被引:2
|
作者
Thomassen, Sofie Ellen [1 ]
von Schreeb, Sebastian [1 ,2 ]
Kirkby, Nikolai Soren [3 ]
Pinholt, Mette [4 ]
Lebech, Anne-Mette [5 ,6 ]
Kronborg, Gitte [1 ,6 ]
Engsig, Frederik Neess [1 ]
机构
[1] Copenhagen Univ Hosp Amager & Hvidovre, Dept Infect Dis, Copenhagen, Denmark
[2] Statens Serum Inst, Infect Dis Epidemiol & Prevent, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshospitalet, Dept Clin Microbiol, Copenhagen, Denmark
[4] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Microbiol, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Rigshospitalet, Dept Infect Dis, Copenhagen, Denmark
[6] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
关键词
Monkeypox; screening; asymptomatic; pre-exposure prophylaxis; HIV pre-exposure prophylaxis; vaccine; vaccination;
D O I
10.1177/09564624231223764
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: During the 2022 outbreak of mpox (previously called monkeypox), which primarily affected Gay, Bisexual, and other Men who have Sex with Men (GBMSM), testing was mainly limited to individuals with symptoms of infection. Although sporadic cases of mpox continue to be diagnosed in Denmark, the feasibility of screening asymptomatic high-risk populations, such as those using HIV pre-exposure prophylaxis (PrEP), is still unknown. Methods: During the autumn of 2022, a rectal swab test for mpox PCR was included in the routine sexually transmitted infections (STI) screening for PrEP users. Results: The screening included 224 asymptomatic men with a median age of 36.5 years. One patient (0.4%) tested positive for mpox. Ten (4.5%) and nine (4.0%) had chlamydia and gonorrhea, respectively. Discussion: Our study demonstrates that screening for mpox is feasible in two Danish PrEP clinics.
引用
收藏
页码:374 / 378
页数:5
相关论文
共 50 条
  • [21] HIV: Pre-exposure Prophylaxis
    Singh, Ajai Kumar
    Singh, Ashish
    Singh, Deepti
    Singh, Manish
    Singh, Pratibha
    Sharma, Abhishek
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (12) : 900 - 901
  • [22] HIV pre-exposure prophylaxis
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2024, 63 (638): : 14 - 16
  • [23] HIV pre-exposure prophylaxis
    Morin, Stephen F.
    Yamey, Gavin
    Rutherford, George W.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [24] Sexual behaviour among users of antiretroviral pre-exposure prophylaxis
    Underhill, Kristen
    Mayer, Kenneth H.
    LANCET INFECTIOUS DISEASES, 2013, 13 (12): : 996 - 997
  • [25] Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake
    Wille, Lexie
    Parent, Mike C.
    AIDS PATIENT CARE AND STDS, 2020, 34 (12) : 499 - 501
  • [26] Adoption of HIV pre-exposure prophylaxis among women at high risk of HIV infection in Kenya
    Bien-Gund, Cedric H.
    Ochwal, Perez
    Marcus, Noora
    Bair, Elizabeth F.
    Napierala, Sue
    Maman, Suzanne
    Agot, Kawango
    Thirumurthy, Harsha
    PLOS ONE, 2022, 17 (09):
  • [27] Pre-exposure prophylaxis for HIV in Austria: A prospective observational study
    Chromy, D.
    Neidhart, T.
    Urban, N.
    Grabmeier-Pfistershammer, K.
    Touzeau-Roemer, V.
    Saluzzo, S.
    Esser, S.
    Weninger, W.
    Willinger, B.
    Rieger, A.
    Bauer, W. M.
    HIV MEDICINE, 2023, 24 : 497 - 498
  • [28] The impact of pre-exposure prophylaxis (PrEP) and screening on the dynamics of HIV
    Pinto, Carla M. A.
    Carvalho, Ana R. M.
    JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS, 2018, 339 : 231 - 244
  • [29] Localized monkeypox infestation in MSM on pre-exposure prophylaxis
    Torster, Leopold
    Tegtmeyer, Jonathan
    Koett, Julian
    Christolouka, Maria
    Schneider, Stefan W.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E366 - E367
  • [30] EXPERIENCES USING PRE-EXPOSURE PROPHYLAXIS FOR HIV PREVENTION AMONG HIGH RISK DRUG USERS
    Shrestha, Roman
    Copenhaver, Michael
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S481 - S481